BlackRock Advisors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-40,277
| Closed | -$82K | – | 3874 |
|
|
2016
Q1 | $82K | Buy |
40,277
+6,667
| +20% | +$11.9K | ﹤0.01% | 3010 |
|
|
2015
Q4 | $83K | Sell |
33,610
-17,866
| -35% | -$53K | ﹤0.01% | 3003 |
|
|
2015
Q3 | $134K | Sell |
51,476
-1,174
| -2% | -$3.06K | ﹤0.01% | 2957 |
|
|
2015
Q2 | $165K | Buy |
52,650
+7,968
| +18% | +$27.3K | ﹤0.01% | 2909 |
|
|
2015
Q1 | $128K | Buy |
44,682
+6,422
| +17% | +$16.4K | ﹤0.01% | 2923 |
|
|
2014
Q4 | $99K | Sell |
38,260
-259,324
| -87% | -$1.13M | ﹤0.01% | 3051 |
|
|
2014
Q3 | $2.22M | Sell |
297,584
-409,888
| -58% | -$3.83M | ﹤0.01% | 1144 |
|
|
2014
Q2 | $8.33M | Buy |
707,472
+154,420
| +28% | +$1.65M | 0.01% | 835 |
|
|
2014
Q1 | $6.42M | Buy |
553,052
+451,052
| +442% | +$5.31M | 0.01% | 915 |
|
|
2013
Q4 | $1.11M | Buy |
102,000
+3,361
| +3% | +$33.1K | ﹤0.01% | 1449 |
|
|
2013
Q3 | $1.06M | Buy |
98,639
+70,668
| +253% | +$805K | ﹤0.01% | 1398 |
|
|
2013
Q2 | $328K | Buy |
+27,971
| New | +$279K | ﹤0.01% | 2143 |
|
BlackRock Advisors's SZYM Position: Q2 2016 in Review
BlackRock Advisors sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 40,277 shares — an estimated $82K sold.
BlackRock Advisors first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $8.33M in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.
- BlackRock Advisors reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
- BlackRock Advisors sold 40,277 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $82K.
- BlackRock Advisors first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
- BlackRock Advisors's SOLAZYME INC COM STK (DE) position peaked at $8.33M in Q2 2014.
- 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.
Based on BlackRock Advisors's 13F filing for Q2 2016, filed 10 Aug 2016.